- ►diabetesjournals.org DM Wilson, RW Beck, WV Tamborlane, MJ … - Diabetes Care, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In 30 children with type 1 diabetes (mean age 11.2
± 4.1 years), the Navigator glucose values were compared with reference serum
glucose values of blood samples obtained in an inpatient clinical research ... Cited by 42 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org RL Weinstein, SL Schwartz, RL Brazg, JR … - Diabetes Care, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Fifty-eight subjects with type 1 diabetes, aged
18–64 years, were enrolled in a multicenter, prospective, single-arm study.
Each subject wore two sensors simultaneously, which were calibrated with ... Cited by 48 - Related articles - BL Direct - All 5 versions
HP Chase, R Beck, W Tamborlane, B … - Diabetes Care, 2005 - ncbi.nlm.nih.gov OBJECTIVE: This study assesses whether use of the GlucoWatch G2 Biographer
(GW2B) in addition to standard glucose monitoring lowers HbA(1c) and reduces
hypoglycemia compared with standard glucose monitoring alone. RESEARCH ... Cited by 29 - Related articles - All 2 versions
- Free from Publisher S Garg, L Jovanovic - Diabetes Care, 2006 - care.diabetesjournals.org.p.angrylapdog.com RESULTS—Of the 6,811 matched self-monitoring of blood glucose to sensor values
prospectively analyzed, 97.2% fell in the Clarke error grid zones A and B, and
median absolute relative difference was 11.4%. After unblinding, subjects ... Cited by 55 - Related articles - BL Direct - All 9 versions
- ►diabetesjournals.org D Deiss, J Bolinder, JP Riveline, T Battelino, … - Diabetes Care, 2006 - Am Diabetes Assoc Intensive self-management with frequent self-monitoring of blood glucose (SMBG)
is important in type 1 diabetes to achieve good metabolic control (1–3).
Nevertheless, many patients still experience episodes of unrecognized hypo- ... Cited by 132 - Related articles - BL Direct - All 9 versions
- Free from Publisher SA Weinzimer, GM Steil, KL Swan, J Dziura, … - Diabetes Care, 2008 - Am Diabetes Assoc OBJECTIVE—The most promising β-cell replacement therapy for children with
type 1 diabetes is a closed-loop artificial pancreas incorporating continuous
glucose sensors and insulin pumps. The Medtronic MiniMed external ... Cited by 30 - Related articles - BL Direct - All 5 versions
- ►alexfok.com [PDF] - Free from Publisher S Garg, H Zisser, S Schwartz, T Bailey, R … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 91 insulin-requiring patients with type
1 (n = 75) and type 2 (n = 16) diabetes were enrolled in this multicenter
randomized study. Subjects wore a transcutaneous, 3-day, continuous glucose- ... Cited by 157 - Related articles - BL Direct - All 10 versions
- ►shouxi.net GM Steil, K Rebrin, C Darwin, F Hariri, MF … - Diabetes, 2006 - Am Diabetes Assoc An automated closed-loop insulin delivery system based on subcutaneous glucose
sensing and subcutaneous insulin delivery was evaluated in 10 subjects with type
1 diabetes (2 men, 8 women, mean [±SD] age 43.4 ± 11.4 years, duration of ... Cited by 43 - Related articles - BL Direct - All 5 versions
